Mangalam Drugs & Organics Ltd. - Outcome of Board Meeting

| Updated on July 26, 2019 Published on July 26, 2019

In terms of Regulation 30 read with part A of Schedule III of the SEBI listing regulations, we have to inform you that the Board of Directors of the Company, in their meeting held today i.e. Friday, July 26, 2019 has inter-alia transacted the following business:

1. Approved the Un-Audited Financial Results for the quarter ended June 30, 2019 along with the Limited Review Report on the results pursuant to Regulation 33 of the Listing Regulations;

2. Approved convening of 46th Annual General Meeting of the Company and other related matters;
3. Approved Re-appointment of Shri Govardhan M. Dhoot (DIN: 01240086) as Managing Director for next term of 5 years with effect from November 1, 2019, whose current term expires on October 31, 2019, subject to shareholders approval being obtained in the ensuing general meeting and such other approvals, if any, required to be obtained pursuant to Companies Act, 2013 and / or the Listing Regulations.

We request you to take the same on your records.

Pdf Link: Mangalam Drugs & Organics Ltd. - Outcome of Board Meeting

Source : BSE - www.bseindia.com

Published on July 26, 2019
This article is closed for comments.
Please Email the Editor